Monday, July 14, 2025

Creating liberating content

Access Denied You don’t have permission to access ” on

Elon musk and the xAI logo. Vincent Feuray | Afp

Not commonly used, Vitamin D injections send the nutrient directly

Related News

Access Denied You don’t have permission to access ” on this server. Reference #18.2ef63717.1752482548.176df6 Source link

Elon musk and the xAI logo. Vincent Feuray | Afp | Getty Images Elon Musk on Monday said he does not support a merger between xAI and Tesla, as questions

Olympic bronze medalist and former world no. 1 badminton player Saina Nehwal has confirmed her separation from her husband and fellow shuttler Parupalli Kashyap after their seven-year-long marriage. The news

Not commonly used, Vitamin D injections send the nutrient directly to the bloodstream. Doctors provide these injections to patients, either on a monthly basis or as required. The most suitable

The WPI inflation had registered at 0.39 per cent in May, whilst it stood at 3.43 per cent in June last year. (AI image) India’s Wholesale Price Index (WPI) inflation

Gibran raises $2.6 million to build nature-inspired, adaptive AI systems (Representative AI image) BENGALURU: AI research startup Gibran has raised $2.6 million in a seed round led by Together Fund

Trending News

Access Denied You don’t have permission to access ” on this server. Reference #18.2ef63717.1752482548.176df6 Source link

Top stocks to buy (AI image) Stock market recommendations: According to Motilal Oswal Financial Services Ltd, the top stock picks for the week (starting July 14, 2025) are Suzlon, and

Bitcoin surged past the $120,000 mark for the first time on Monday, setting a new record as optimism grows over potential regulatory clarity in the US.Bitcoin reached a new all-time

Market experts indicate that ongoing uncertainty in trade talks could maintain markets in a consolidative phase. (AI image) Stock market today: Nifty50 and BSE Sensex, the Indian equity benchmark indices,

NEW DELHI: In an event-heavy week, stock investors will track quarterly earnings of several bluechip firms, likely outcome of ongoing India-US trade talks, and inflation data for market cues, analysts

NEW DELHI: Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra said in the company’s annual report for

Bajaj Finance share price hits 52-week high; stock delivers with 36% returns, Rs 1.5 lakh crore value creation in 2025

Word Count: 630 | Estimated Reading Time: 4 minutes


Bajaj Finance share price hits 52-week high; stock delivers with 36% returns, Rs 1.5 lakh crore value creation in 2025
Bajaj Finance share price hits 52-week high

Bajaj Finance share price today: In a remarkable display of market performance, Bajaj Finance has outperformed its Nifty counterparts this year, generating a 36 per cent year-to-date return and creating Rs 1.5 lakh crore in investor value.
The company’s market capitalisation is approaching Rs 6 lakh crore, following its climb to a new 52-week peak of Rs 9,315 on Monday, signalling a significant breakthrough. Analysts are revising their price targets upwards, with CLSA setting a target of Rs 11,000, quoting, “Form is temporary, class is permanent.”
Elara Capital has raised its target to Rs 11,161, according to an ET report. Elara anticipates a 25 per cent AUM CAGR for Bajaj Finance during FY24-27, citing its robust business structure and growth catalysts. The NBFC is capitalising on favourable market conditions whilst expanding significantly in rural areas, having doubled its presence in 18 months. “Bajaj Finance’s diversification into high-growth areas such as gold loans, microfinance, and tractor loans will further bolster its growth trajectory,” said Elara.
The organisation’s cross-sell operations are showing positive results, with 62 per cent of customers contributing to a per customer profit of six. Ventura Securities commenced coverage with a BUY rating and Rs 10,205 target while the recent leadership changes have reinforced stakeholder confidence.
Regarding valuation considerations, OmniScience Capital’s Vikas Gupta observed that Bajaj Finance’s P/E ratio has increased from 26-27 in November to 35-36, approaching fair value.
BNP Paribas maintained a cautious stance, noting potential market oversight of peak borrowing costs expected in Q2FY25. They predict increased provisions for stressed segments, whilst acknowledging possible sentiment impacts in Q4FY25.
Nevertheless, the overall outlook remains positive, with analysts confident in Bajaj Finance’s sustained growth potential, supported by its diversified operations and market leadership. Investors will monitor quarterly results closely, particularly considering rising borrowing costs and potential personal loan market changes.





Source link

Most Popular Articles

Sign In

Welcome ! Log into Your Account